414 related articles for article (PubMed ID: 10835283)
1. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
Kristensen SM; Siegal G; Sankar A; Driscoll PC
J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
[TBL] [Abstract][Full Text] [Related]
2. Calculation of absolute protein-ligand binding constants with the molecular dynamics free energy perturbation method.
Woo HJ
Methods Mol Biol; 2008; 443():109-20. PubMed ID: 18446284
[TBL] [Abstract][Full Text] [Related]
3. Characterization of enzyme motions by solution NMR relaxation dispersion.
Loria JP; Berlow RB; Watt ED
Acc Chem Res; 2008 Feb; 41(2):214-21. PubMed ID: 18281945
[TBL] [Abstract][Full Text] [Related]
4. Conformational and dynamics changes induced by bile acids binding to chicken liver bile acid binding protein.
Eberini I; Guerini Rocco A; Ientile AR; Baptista AM; Gianazza E; Tomaselli S; Molinari H; Ragona L
Proteins; 2008 Jun; 71(4):1889-98. PubMed ID: 18175325
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
Batra-Safferling R; Granzin J; Mödder S; Hoffmann S; Willbold D
Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamics of phosphotyrosine peptide-peptoid hybrids binding to the p56lck SH2 domain.
Dekker FJ; Mol NJ; Liskamp RM
J Pept Sci; 2010 Jul; 16(7):322-8. PubMed ID: 20552566
[TBL] [Abstract][Full Text] [Related]
7. Modulation of SHP-1 phosphatase activity by monovalent and bivalent SH2 phosphopeptide ligands.
Teichmann K; Kühl T; Könnig I; Wieligmann K; Zacharias M; Imhof D
Biopolymers; 2010 Jan; 93(1):102-12. PubMed ID: 19768778
[TBL] [Abstract][Full Text] [Related]
8. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
Pletneva EV; Sundd M; Fulton DB; Andreotti AH
J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
[TBL] [Abstract][Full Text] [Related]
9. Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.
Nachman J; Gish G; Virag C; Pawson T; Pomès R; Pai E
PLoS One; 2010 Jun; 5(6):e11215. PubMed ID: 20574521
[TBL] [Abstract][Full Text] [Related]
10. Solution structure and backbone dynamics of human Raf-1 kinase inhibitor protein.
Guo C; Yi C; Peng Y; Wen Y; Lin D
Biochem Biophys Res Commun; 2013 Aug; 438(1):129-32. PubMed ID: 23872143
[TBL] [Abstract][Full Text] [Related]
11. Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: implications for drug design.
Taylor JD; Ababou A; Fawaz RR; Hobbs CJ; Williams MA; Ladbury JE
Proteins; 2008 Dec; 73(4):929-40. PubMed ID: 18536014
[TBL] [Abstract][Full Text] [Related]
12. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
Angulo J; Enríquez-Navas PM; Nieto PM
Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and activities of backbone-side chain cyclic octapeptide ligands with N-functionalized phosphotyrosine for the N-terminal SH2-domain of the protein tyrosine phosphatase SHP-1.
Zoda MS; Zacharias M; Reissmann S
J Pept Sci; 2010 Aug; 16(8):403-13. PubMed ID: 20582921
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization.
DeLorbe JE; Clements JH; Teresk MG; Benfield AP; Plake HR; Millspaugh LE; Martin SF
J Am Chem Soc; 2009 Nov; 131(46):16758-70. PubMed ID: 19886660
[TBL] [Abstract][Full Text] [Related]
15. ¹H, ¹³C and ¹⁵N backbone and side-chain chemical shift assignments of the free and bound forms of the human PTPN11 second SH2 domain.
Rubio L; Huculeci R; Buts L; Vanwetswinkel S; Lenaerts T; van Nuland NA
Biomol NMR Assign; 2014 Oct; 8(2):297-301. PubMed ID: 23838815
[TBL] [Abstract][Full Text] [Related]
16. Functional implications of the conformational switch in AICD peptide upon binding to Grb2-SH2 domain.
Das S; Raychaudhuri M; Sen U; Mukhopadhyay D
J Mol Biol; 2011 Nov; 414(2):217-30. PubMed ID: 22001015
[TBL] [Abstract][Full Text] [Related]
17. 1H, 13C and 15N backbone and side-chain chemical shift assignment of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.
Huculeci R; Buts L; Lenaerts T; van Nuland NA
Biomol NMR Assign; 2011 Oct; 5(2):181-4. PubMed ID: 21298565
[TBL] [Abstract][Full Text] [Related]
18. Conformational flexibility of a human immunoglobulin light chain variable domain by relaxation dispersion nuclear magnetic resonance spectroscopy: implications for protein misfolding and amyloid assembly.
Mukherjee S; Pondaven SP; Jaroniec CP
Biochemistry; 2011 Jul; 50(26):5845-57. PubMed ID: 21627161
[TBL] [Abstract][Full Text] [Related]
19. Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding.
Ward JM; Gorenstein NM; Tian J; Martin SF; Post CB
J Am Chem Soc; 2010 Aug; 132(32):11058-70. PubMed ID: 20698672
[TBL] [Abstract][Full Text] [Related]
20. The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.
Liu BA; Engelmann BW; Nash PD
FEBS Lett; 2012 Aug; 586(17):2597-605. PubMed ID: 22569091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
